Isoquercetin Ameliorates Myocardial Infarction Through Anti-Inflammation And Anti-Apoptosis Factor And Regulating Tlr4-Nf-Kappa B Signal Pathway

The aim of the present study was to investigate the protective mechanisms and identify the effects of isoquercetin on myocardial infarction in a rat model of acute myocardial infarction (AMI). Isoquercetin ameliorated myocardial infarct size, creatine kinase (CK), CK-MB and lactic dehydrogenase activity and inhibited inflammation, oxidative stress and heart cell apoptosis in a rat with AMI. Isoquercetin increased endothelial nitric oxide synthase, reduced inducible nitric oxide synthase levels and suppressed the Toll-like receptor 4-nuclear factor (TLR4-NF)-kappa B signaling pathway in a rat with AMI. Overall, isoquercetin ameliorated AMI through anti-inflammatory and anti-apoptotic factors, and regulation of the TLR4-NF-kappa B signaling pathway. Isoquercetin may therefore potentially exert a protective effect against AMI or other heart diseases.